Journal of the American Society of Hypertension
Volume 1, Issue 5 , Pages 302-340 , September 2007

Central arterial aging and the epidemic of systolic hypertension and atherosclerosis

  • Edward G. Lakatta, MD

      Affiliations

    • Corresponding Author InformationCorresponding author: Edward G. Lakatta, MD, Laboratory of Cardiovascular Science, Gerontology Research Center, 5600 Nathan Shock Drive, Baltimore, Maryland 21224. Tel: 410-558-8202; fax: 410-558-8150.

Received 9 January 2007 ,Accepted 9 May 2007.

References 

  1. Najjar SS, Scuteri A, Lakatta EG. Arterial aging: is it an immutable cardiovascular risk factor?. Hypertension. 2005;46:454–462
  2. Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part I: aging arteries: a “set-up” for vascular disease. Circulation. 2003;107:139–146
  3. Najjar SS, Lakatta EG. Vascular aging: from molecular to clinical cardiology. In: The Textbook of Molecular Cardiology. Totowa, New Jersey: Humana Press; 2002;p. 517–547
  4. Wang M, Lakatta EG. Central arterial aging: humans to molecules. In:  Safar M editors. Handbook of Hypertension: Arterial Stiffness in Hypertension. Elsevier; 2006;p. 137–160
  5. Gerstenblith G, Frederiksen J, Yin FC, et al. Echocardiographic assessment of a normal adult aging population. Circulation. 1977;56:273–278
  6. Nagai Y, Metter EJ, Earley CJ, et al. Increased carotid artery intimal-medial thickness in asymptomatic older subjects with exercise-induced myocardial ischemia. Circulation. 1998;98:1504–1509
  7. Vaitkevicius PV, Fleg JL, Engel JH, et al. Effects of age and aerobic capacity on arterial stiffness in healthy adults. Circulation. 1993;88:1456–1462
  8. Celermajer DS, Sorensen KE, Spiegelhalter DJ, et al. Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. J Am Coll Cardiol. 1994;24:471–476
  9. Lakatta EG. Cardiovascular regulatory mechanisms in advanced age. Physiol Rev. 1993;73:413–467
  10. Virmani R, Avolio AP, Mergner WJ, et al. Effect of aging on aortic morphology in populations with high and low prevalence of hypertension and atherosclerosis (Comparison between occidental and Chinese communities). Am J Pathol. 1991;139:1119–1129
  11. Woo KS, Chook P, Raitakari OT, et al. Westernization of Chinese adults and increased subclinical atherosclerosis. Arterioscler Thromb Vasc Biol. 1999;19:2487–2493
  12. Adams MR, Nakagomi A, Keech A, et al. Carotid intima-media thickness is only weakly correlated with the extent and severity of coronary artery disease. Circulation. 1995;92:2127–2134
  13. Li Z, Froehlich J, Galis ZS, et al. Increased expression of matrix metalloproteinase-2 in the thickened intima of aged rats. Hypertension. 1999;33:116–123
  14. Wang M, Lakatta EG. Altered regulation of matrix metalloproteinase-2 in aortic remodeling during aging. Hypertension. 2002;39:865–873
  15. Wang M, Takagi G, Asai K, et al. Aging increases aortic MMP-2 activity and angiotensin II in nonhuman primates. Hypertension. 2003;41:1308–1316
  16. Bode-Boger SM, Muke J, Surdacki A, et al. Oral L-arginine improves endothelial function in healthy individuals older than 70 years. Vasc Med. 2003;8:77–81
  17. Wilkinson IB, Franklin SS, Cockcroft JR. Nitric oxide and the regulation of large artery stiffness: from physiology to pharmacology. Hypertension. 2004;44:112–116
  18. Lakatta EG. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises (Part III: cellular and molecular clues to heart and arterial aging). Circulation. 2003;107:490–497
  19. Blacher J, Guerin AP, Pannier B, et al. Impact of aortic stiffness on survival in end-stage renal disease. Circulation. 1999;99:2434–2439
  20. Kelly R, Hayward C, Avolio A, et al. Noninvasive determination of age-related changes in the human arterial pulse. Circulation. 1989;80:1652–1659
  21. Chen CH, Nevo E, Fetics B, et al. Estimation of central aortic pressure waveform by mathematical transformation of radial tonometry pressure (Validation of generalized transfer function). Circulation. 1997;95:1827–1836
  22. Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part II: the aging heart in health: links to heart disease. Circulation. 2003;107:346–354
  23. McVeigh GE, Bratteli CW, Morgan DJ, Alinder CM, Glasser SP, Finkelstein SM, et al. Age-related abnormalities in arterial compliance identified by pressure pulse contour analysis: aging and arterial compliance. Hypertension. 1999;33:1392–1398
  24. McVeigh GE, Allen PB, Morgan DR, et al. Nitric oxide modulation of blood vessel tone identified by arterial waveform analysis. Clin Sci (Lond). 2001;100:387–393
  25. Mitchell GF. Increased aortic stiffness: an unfavorable cardiorenal connection. Hypertension. 2004;43:151–153
  26. Safar ME, London GM, Plante GE. Arterial stiffness and kidney function. Hypertension. 2004;43:163–168
  27. O’Rourke MF. Arterial Function in Health and Disease. In: New York, New York: Churchill Livingstone; 1982;p. 275
  28. O’Rourke MF. Vascular impedance in studies of arterial and cardiac function. Physiol Rev. 1982;62:570–623
  29. Nichols WW, O’Rourke MF, Avolio AP, et al. Effects of age on ventricular-vascular coupling. Am J Cardiol. 1985;55:1179–1184
  30. Nichols WW, O’Rourke MF, Avolio AP, et al. Age-related changes in left ventricular/arterial coupling. In:  Yin FCP editors. Ventricular Vascular Coupling: Clinical Physiology, and Engineering Aspects. New York, New York: Springer-Verlag; 1987;p. 79–114
  31. Carroll JD, Shroff S, Wirth P, et al. Arterial mechanical properties in dilated cardiomyopathy: aging and the response to nitroprusside. J Clin Invest. 1991;87:1002–1009
  32. Fleg JL, Gerstenblith G, Schulman SP, et al. Gender differences in exercise hemodynamics of older subjects: effects of conditioning status. Circulation. 1990;82:(abstract) III–239
  33. Nichols WW, O’Rourke MF, Avolio AP, et al. Ventricular/vascular interaction in patients with mild systemic hypertension and normal peripheral resistance. Circulation. 1986;74:455–462
  34. Rodeheffer RJ, Gerstenblith G, Becker LC, et al. Exercise cardiac output is maintained with advancing age in healthy human subjects: cardiac dilatation and increased stroke volume compensate for a diminished heart rate. Circulation. 1984;69:203–213
  35. Peterson LH, Jensen RE, Parnell J. Mechanical properties of arteries in vivo. Circ Res. 1960;8:622–639
  36. Remington JW. The physiology of the aorta and major arteries. In: Handbook of Physiology (Circulation). Washington, DC: American Physiology Society; 1963;p. 808
  37. Safar ME, Toto-Moukouo JJ, Bouthier JA, et al. Arterial dynamics, cardiac hypertrophy, and antihypertensive treatment. Circulation. 1987;75(suppl I):I156–I161
  38. Simon AC, Levenson JA, Bouthier JL, et al. Captopril-induced changes in large arteries in essential hypertension. Am J Med. 1984;76:71–75
  39. Ting CT, Brin KP, Lin SJ, Wang SP, et al. Arterial hemodynamics in human hypertension. J Clin Invest. 1986;78:1462–1471
  40. Murgo JP, Westerhof N, Giolma JP, Altobelli SA. Effects of exercise on aortic input impedance and pressure wave forms in normal humans. Circ Res. 1981;48:334–343
  41. Yin FCP, Weisfeldt ML, Milnor WR. Role of aortic input impedance in the decreased cardiovascular response to exercise with aging in dogs. J Clin Invest. 1981;68:28–38
  42. Yin FCP, Spurgeon HA, Kallman CH. Age-associated alterations in viscoelastic properties of canine aortic strips. Circ Res. 1983;53:464–472
  43. Elzinga G, Westerhof N. Pressure and flow generated by the left ventricle against different impedances. Circ Res. 1973;32:178–186
  44. Nichols WW, Pepine CJ. Left ventricular afterload and aortic input impedance: implications of pulsatile bold flow. Prog Cardiovasc Dis. 1982;24:293–306
  45. Nichols WW, Pepine CJ, Feldman RL, et al. Influence of changes in pulsatile components of vascular load on left ventricular function: power-load relations in patients without heart failure. Circulation. 1979;60:(abstract) II–94
  46. Sunagawa K, Maughan WL, Sagawa K. Optimal arterial resistance for the maximal stroke work studied in isolated canine left ventricle. Circ Res. 1985;56:586–595
  47. Olivetti G, Melissari M, Capasso JM, et al. Cardiomyopathy of the aging human heart (Myocyte loss and reactive cellular hypertrophy). Circ Res. 1991;68:1560–1568
  48. Unverferth DV, Fetters JK, Unverferth BJ, et al. Human myocardial histologic characteristics in congestive heart failure. Circulation. 1983;68:1194–1200
  49. Gardin JM, Henry WL, Savage DD, et al. Echocardiographic measurements in normal subjects: evaluation of an adult population without clinically apparent heart disease. J Clin Ultrasound. 1979;7:439–447
  50. Sjogren AL. Left ventricular wall thickens determined by ultrasound in 100 subjects without heart disease. Chest. 1971;60:341–346
  51. Isnard RN, Pannier BM, Laurent S, et al. Pulsatile diameter and elastic modulus of the aortic arch in essential hypertension: a noninvasive study. J Am Coll Cardiol. 1989;13:399–405
  52. Fleg JL, O’Connor F, Gerstenblith G, et al. Impact of age on the cardiovascular response to dynamic upright exercise in healthy men and women. J Appl Physiol. 1995;78:890–900
  53. Najjar SS, Schulman SP, Gerstenblith G, et al. Age and gender affect ventricular-vascular coupling during aerobic exercise. J Am Coll Cardiol. 2004;144:611–617
  54. Arnett DK, Tyroler HA, Burke G, et al. Hypertension and subclinical carotid artery atherosclerosis in blacks and whites: the Atherosclerosis Risk in Communities Study (ARIC Investigators). Arch Intern Med. 1996;156:1983–1989
  55. Nichols WW, Nicolini FA, Pepine CJ. Determinants of isolated systolic hypertension in the elderly. J Hypertens Suppl. 1992;10:S73–S77
  56. Laurent S, Lacolley P, Girerd X, et al. Arterial stiffening: opposing effects of age- and hypertension-associated structural changes. Can J Physiol Pharmacol. 1996;74:842–849
  57. O’Rourke MF, Nichols WW. Aortic diameter, aortic stiffness, and wave reflection increase with age and isolated systolic hypertension. Hypertension. 2005;45:652–658
  58. Mitchell GF, Lacourciere Y, Ouellet JP, et al. Determinants of elevated pulse pressure in middle-aged and older subjects with uncomplicated systolic hypertension: the role of proximal aortic diameter and the aortic pressure-flow relationship. Circulation. 2003;108:1592–1598
  59. Chobanian AV, Bakris GL, Black HR, et al. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206–1252
  60. Giles TD, Berk BC, Black HR, et al. Expanding the definition and classification of hypertension (Greenwich). J Clin Hypertens. 2005;7:505–512
  61. Perticone F, Ceravolo R, Pujia A, et al. Prognostic significance of endolethial dysfunction in hypertensive patients. Circulation. 2001;104:191–196
  62. Laurent S, Boutouyrie P, Asmar R, et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension. 2001;37:1236–1241
  63. Taddei S, Virdis A, Mattei P, et al. Hypertension causes premature aging of endothelial function in humans. Hypertension. 1997;29:736–743
  64. Taddei S, Virdis A, Mattei P, et al. Defective L-arginine-nitric oxide pathway in offspring of essential hypertensive patients. Circulation. 1996;94:1298–1303
  65. Benetos A, Okuda K, Lajemi M, et al. Telomere length as an indicator of biological aging: the gender effect and relation with pulse pressure and pulse wave velocity. Hypertension. 2001;37:381–385
  66. Kannel WB. Elevated systolic blood pressure as a cardiovascular risk factor. Am J Cardiol. 2000;85:251–255
  67. Sesso HD, Stampfer MJ, Rosner B, et al. Systolic and diastolic blood pressure, pulse pressure, and mean arterial pressure as predictors of cardiovascular disease risk in men. Hypertension. 2000;36:801–807
  68. Neutel JM. Beyond the sphygmomanometric numbers: hypertension as a syndrome. Am J Hypertens. 2001;14:250S–257S
  69. Liao D, Arnett DK, Tyroler HA, et al. Arterial stiffness and the development of hypertension: the ARIC Study. Hypertension. 1999;34:201–206
  70. Blacher J, Pannier B, Guerin AP, et al. Carotid arterial stiffness as a predictor of cardiovascular and all-cause mortality in end-stage renal disease. Hypertension. 1998;32:570–574
  71. Boutouyrie P, Tropeano AI, Asmar R, et al. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a Longitudinal Study. Hypertension. 2002;39:10–15
  72. Willum-Hansen T, Staessen JA, Torp-Pedersen C, et al. Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation. 2006;113:664–670
  73. Mattace-Raso FU, van der Cammen TJ, Knetsch AM, et al. Arterial stiffness as the candidate underlying mechanism for postural blood pressure changes and orthostatic hypotension in older adults: the Rotterdam Study. J Hypertens. 2006;24:339–344
  74. Sutton-Tyrrell K, Najjar SS, Boudreau RM, et al. Health ABC Study Elevated aortic pulse wave velocity, a marker of arterial stiffness, predicts cardiovascular events in well-functioning older adults. Circulation. 2005;111:3384–3390
  75. de Simone G, Roman MJ, Koren MJ, et al. Stroke volume/pulse pressure ratio and cardiovascular risk in arterial hypertension. Hypertension. 1999;33:800–805
  76. Blacher J, Asmar R, Djane S, et al. Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension. 1999;33:1111–1117
  77. Guerin AP, Blacher J, Pannier B, et al. Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation. 2001;103:987–992
  78. London GM, Blacher J, Pannier B, et al. Arterial wave reflections and survival in end-stage renal failure. Hypertension. 2001;38:434–438
  79. Scuteri A, Chen CH, Yin FC, et al. Functional correlates of central arterial geometric phenotypes. Hypertension. 2001;38:1471–1475
  80. Scuteri A, Manolio TA, Marino EK, et al. Prevalence of specific variant carotid geometric patterns and incidence of cardiovascular events in older persons: the Cardiovascular Health Study (CHS E-131). J Am Coll Cardiol. 2004;43:187–193
  81. Graner M, Varpula M, Kahri J, et al. Association of carotid intima-media thickness with angiographic severity and extent of coronary artery disease. Am J Cardiol. 2006;97:624–629
  82. van Popele NM, Grobbee DE, Bots ML, et al. Association between arterial stiffness and atherosclerosis: the Rotterdam Study. Stroke. 2001;32:454–460
  83. Weber T, Auer J, O’Rourke MF, et al. Arterial stiffness, wave reflections, and the risk of coronary artery disease. Circulation. 2004;109:184–189
  84. Samani NJ, Boultby R, Butler R, et al. Telomere shortening in atherosclerosis. Lancet. 2001;358:472–473
  85. Aminbakhsh A, Mancini GB. Carotid intima-media thickness measurements: what defines an abnormality? (A systematic review). Clin Invest Med. 1999;22:149–157
  86. Chambless LE, Folsom AR, Clegg LX, et al. Carotid wall thickness is predictive of incident clinical stroke: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol. 2000;151:478–487
  87. O’Leary DH, Polak JF, Kronmal RA, et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults (Cardiovascular Health Study collaborative research group). N Engl J Med. 1999;340:14–22
  88. Scuteri A, Najjar SS, Muller DC, et al. Metabolic syndrome amplifies the age-associated increases in vascular thickness and stiffness. J Am Coll Cardiol. 2004;43:1388–1395
  89. Sutton-Tyrrell K, Newman A, Simonsick EM, et al. Aortic stiffness is associated with visceral adiposity in older adults enrolled in the study of health, aging, and body composition. Hypertension. 2001;38:429–433
  90. Mackey RH, Sutton-Tyrrell K, Vaitkevicius PV, et al. Correlates of aortic stiffness in elderly individuals: a subgroup of the Cardiovascular Health Study. Am J Hypertens. 2002;15:16–23
  91. Salomaa V, Riley W, Kark JD, et al. Non-insulin-dependent diabetes mellitus and fasting glucose and insulin concentrations are associated with arterial stiffness indexes: the ARIC Study (Atherosclerosis Risk in Communities Study). Circulation. 1995;91:1432–1443
  92. Wagenknecht LE, Zaccaro D, Espeland MA, et al. Diabetes and progression of carotid atherosclerosis: the Insulin Resistance Atherosclerosis Study. Arterioscler Thromb Vasc Biol. 2003;23:1035–1041
  93. Schofield I, Malik R, Izzard A, et al. Vascular structural and functional changes in type 2 diabetes mellitus: evidence for the roles of abnormal myogenic responsiveness and dyslipidemia. Circulation. 2002;106:3037–3043
  94. Balletshofer BM, Rittig K, Enderle MD, et al. Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with type 2 diabetes in association with insulin resistance. Circulation. 2000;101:1780–1784
  95. Jeanclos E, Krolewski A, Skurnick J, et al. Shortened telomere length in white blood cells of patients with IDDM. Diabetes. 1998;47:482–486
  96. Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med. 1988;318:1315–1321
  97. Amar J, Ruidavets JB, Chamontin B, et al. Arterial stiffness and cardiovascular risk factors in a population-based study. J Hypertens. 2001;19:381–387
  98. McVeigh G, Brennan G, Hayes R, Cohn J, Finkelstein S, Johnston D. Vascular abnormalities in non-insulin-dependent diabetes mellitus identified by arterial waveform analysis. Am J Med. 1993;95:424–430
  99. Wolinsky H, Glagov S. Structural basis for the static mechanical properties of the aortic media. Circ Res. 1964;14:400–413
  100. Wolinsky H, Glagov S. A lamellar unit of aortic medial structure and function in mammals. Circ Res. 1967;20:99–111
  101. Wolinsky H, Glagov S. Comparison of abdominal and thoracic aortic medial structure in mammals: deviation of man from the usual pattern. Circ Res. 1969;25:677–686
  102. Dontas AS, Taylor HC, Keys A. Carotid pressure plethysmograms: effects of age, diastolic pressure, relative body weight, and physical activity. Arch Kreisluufforsch. 1961;36:49–58
  103. Freis ED, Heath WC, Luchsinger PC, Snell RE. Changes in the carotid pulse which occur with age and hypertension. Am Heart J. 1966;71:757–765
  104. Haynes FW, Ellis LB, Weiss S. Pulse wave velocity and arterial elasticity in arterial hypertension, arteriosclerosis, and related conditions. Am Heart J. 1936;11:385–401
  105. Lansing AI. The Arterial Wall: Aging, Structure, and Chemistry. In: Baltimore, Maryland: Williams & Wilkins; 1959;p. 136–160
  106. Nakashima T, Tanikawa J. A study of human aortic distensibility with relations to atherosclerosis and aging. Angiology. 1971;22:477–490
  107. Orlandi A, Mauriello A, Marino B, et al. Age-related modifications of aorta and coronaries in the rabbit: a morphological and morphometrical assessment. Arch Gerontol Geriatr. 1993;17:37–53
  108. Kaplan D, Meyer K. Mucopolysaccharides of aorta at various ages. Proc Sot Exp Biol Med. 1960;105:78–81
  109. Aronson D. Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes. J Hypertens. 2003;21:3–12
  110. Yan SF, Ramasamy R, Naka Y, et al. Glycation, inflammation, and RAGE: a scaffold for the macrovascular complications of diabetes and beyond. Circ Res. 2003;93:1159–1169
  111. Cantini C, Kieffer P, Corman B, et al. Aminoguanidine and aortic wall mechanics, structure, and composition in aged rats. Hypertension. 2001;38:943–948
  112. Vaitkevicius PV, Lane M, Spurgeon H, et al. A cross-link breaker has sustained effects on arterial and ventricular properties in older rhesus monkeys. Proc Natl Acad Sci U S A. 2001;98:1171–1175
  113. Wolffenbuttel BH, Boulanger CM, Crijns FR, et al. Breakers of advanced glycation end products restore large artery properties in experimental diabetes. Proc Natl Acad Sci U S A. 1998;95:4630–4634
  114. Kass DA, Shapiro EP, Kawaguchi M, et al. Improved arterial compliance by a novel advanced glycation end-product cross-link breaker. Circulation. 2004;104:1464–1470
  115. Chen J, Bridsky SV, Goligorsky DM, et al. Glycated collagen I induces premature senescence-like phenotypic changes in endothelial cells. Circ Res. 2002;90:1290–1298
  116. Li JH, Huang XR, Zhu HJ, et al. Advanced glycation end products activate SMAD signaling via TGF-beta-dependent and independent mechanisms: implications for diabetic renal and vascular disease. FASEB J. 2004;18:176–178
  117. Basta G, Schmidt AM, De Caterina R. Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. Cardiovasc Res. 2004;63:582–592
  118. Ichii T, Koyama H, Tanaka S, et al. Fibrillar collagen specifically regulates human vascular smooth muscle cell genes involved in cellular responses and the pericellular matrix environment. Circ Res. 2001;88:460–467
  119. Price PA, June HH, Buckley JR, et al. Osteoprotegerin inhibits artery calcification induced by warfarin and by vitamin D. Arterioscler Thromb Vasc Biol. 2001;21:1610–1616
  120. Parhami F, Demer LL. Arterial calcification in face of osteoporosis in aging: can we blame oxidized lipids?. Curr Opin Lipidol. 1997;8:312–314
  121. Rutsch F, Terkeltaub R. Parallels between arterial and cartilage calcification: what understanding artery calcification can teach us about chondrocalcinosis. Curr Opin Rheumatol. 2003;15:302–310
  122. Roach MR, Burton AC. The effect of age on the elasticity of human iliac arteries. Can J Biochem Physiol. 1959;37:557–570
  123. Faber M, Moller-Hou G. The human aorta (V. Collagen and elastin in the normal and hypertensive aorta). Acta Pathol Microbial Scand. 1952;31:377–382
  124. Harding SE, Jones SM, O’Gara P, et al. Isolated ventricular myocytes from failing and nonfailing human heart: the relation of age and clinical status of patients to isoproterenol response. J Mol Cell Cardiol. 1992;24:549–564
  125. King AL. Pressure-volume relation for cylindrical tubes with elastomeric walls: the human aorta. J Appl Physics. 1946;17:501–505
  126. Dempsey EW, Lansing A. 1. Elastic tissue. Intern Rev Cytol. 1954;3:437–453
  127. Robert L, Robert B, Robert AM. Molecular biology of elastin as related to aging and atherosclerosis. Exp Gerontol. 1970;5:339–356
  128. Wolinsky H. Long-term effects of hypertension on the rat aortic wall and their relation to concurrent aging changes (Morphological and chemical studies). Circ Res. 1972;30:301–309
  129. Seligman M, Eilberg RF, Fishman L. Mineralization of elastin extracted from human aortic tissues. Calcif Tissue Res. 1975;17:229–234
  130. Labat-Robert J. Cell-matrix interactions in aging: role of receptors and matricryptins. Aging Res Rev. 2004;3:233–247
  131. Teti A. Regulation of cellular functions by extracellular matrix. J Am Soc Nephrol. 1992;2:S83–S87
  132. Wachi H, Seyama Y, Yamashita S, et al. Enhanced tropoelastin-degrading activity during cell passages in cultured smooth muscle cells. Biochim Biophys Acta. 1995;1243:393–398
  133. Foster JA, Rich CB, Miller M, et al. Effect of age and IGF-I administration on elastin gene expression in rat aorta. J Gerontol. 1990;45:B113–B118
  134. Kielty CM, Sherratt MJ, Shuttleworth CA. Elastic fibres. J Cell Sci. 2002;115:2817–2828
  135. Chesler NC, Ku DN, Galis ZS. Transmural pressure induces matrix-degrading activity in porcine arteries ex vivo. Am J Physiol. 1999;277:H2002–H2009
  136. Li Z, Cheng H, Lederer WJ, et al. Enhanced proliferation and migration and altered cytoskeletal proteins in early passage smooth muscle cells from young and old rat aortic explants. Exp Mol Pathol. 1997;64:1–11
  137. Gennaro G, Menard C, Giasson E, et al. Role of p44/p42 MAP kinase in the age-dependent increase in vascular smooth muscle cell proliferation and neointimal formation. Arterioscler Thromb Vasc Biol. 2003;23:204–210
  138. Rivard A, Principe N, Andres V. Age-dependent increase in c-fos activity and cyclin A expression in vascular smooth muscle cells (A potential link between aging, smooth muscle cell proliferation and atherosclerosis). Cardiovasc Res. 2000;45:1026–1034
  139. Yoshida Y, Mitsumata M, Ling G, et al. Migration of medial smooth muscle cells to the intima after balloon injury. Ann NY Acad Sci. 1997;811:459–470
  140. Pauly RR, Passaniti A, Crow M, et al. Experimental models that mimic the differentiation and dedifferentiation of vascular cells. Circulation. 1992;86:III68–III73
  141. Spinetti G, Wang M, Monticone R, et al. Rat aortic MCP-1 and its receptor CCR2 increase with age and alter vascular smooth muscle cell function. Arterioscler Thromb Vasc Biol. 2004;24:1397–1402
  142. Motwani JG, Topol EJ. Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention. Circulation. 1998;97:916–931
  143. Wang M, Zhang J, Jiang L-Q, et al. A Proinflammatory profile within the grossly normal human aortic wall accompanies advancing age. Hypertension. 2007;50:219–227
  144. Asai K, Kudej RK, Shen YT, et al. Peripheral vascular endothelial dysfunction and apoptosis in old monkeys. Arterioscler Thromb Vasc Biol. 2000;20:1493–1499
  145. Shi Q, Aida K, Vandeberg JL, et al. Passage-dependent changes in baboon endothelial cells—relevance to in vitro aging. DNA Cell Biol. 2004;23:502–509
  146. Wagner M, Hampel B, Bernhard D, et al. Replicative senescence of human endothelial cells in vitro involves G1 arrest, polyploidization and senescence-associated apoptosis. Exp Gerontol. 2001;36:1327–1347
  147. Niu S, Matsuda T. Endothelial cell senescence inhibits unidirectional endothelialization in vitro. Cell Transplant. 1992;1:355–364
  148. Yeh HI, Chang HM, Lu WW, et al. Age-related alteration of gap junction distribution and connexin expression in rat aortic endothelium. J Histochem Cytochem. 2000;48:1377–1389
  149. Chang E, Harley CB. Telomere length and replicative aging in human vascular tissues. Proc Natl Acad Sci U S A. 1995;92:11190–11194
  150. Iwama H, Ohyashiki K, Ohyashiki JH, et al. Telomeric length and telomerase activity vary with age in peripheral blood cells obtained from normal individuals. Hum Genet. 1998;102:397–402
  151. Orlandi A, Marcellini M, Spagnoli LG. Aging influences development and progression of early aortic atherosclerotic lesions in cholesterol-fed rabbits. Arterioscler Thromb Vasc Biol. 2000;20:1123–1136
  152. Morisaki N, Saito I, Tamura K, et al. New indices of ischemic heart disease and aging: studies on the serum levels of soluble intercellular adhesion molecule-1 (ICAM-1) and soluble vascular cell adhesion molecule-1 (VCAM-1) in patients with hypercholesterolemia and ischemic heart disease. Atherosclerosis. 1997;131:43–48
  153. Comi P, Chiaramonte R, Maier JA. Senescence-dependent regulation of type 1 plasminogen activator inhibitor in human vascular endothelial cells. Exp Cell Res. 1995;219:304–308
  154. Belmin J, Corman B, Merval R, et al. Age-related changes in endothelial permeability and distribution volume of albumin in rat aorta. Am J Physiol. 1993;264:H679–H685
  155. Matz RL, Andriantsitohaina R. Age-related endothelial dysfunction: potential implications for pharmacotherapy. Drugs Aging. 2003;20:527–550
  156. Cernadas MR, Sanchez de Miguel L, Garcia-Duran M, et al. Expression of constitutive and inducible nitric oxide synthases in the vascular wall of young and aging rats. Circ Res. 1998;83:279–286
  157. Chou TC, Yen MH, Li CY, et al. Alterations of nitric oxide synthase expression with aging and hypertension in rats. Hypertension. 1998;31:643–648
  158. Berkowitz DE, White R, Li D, et al. Arginase reciprocally regulates nitric oxide synthase activity and contributes to endothelial dysfunction in aging blood vessels. Circulation. 2003;108:2000–2006
  159. Van der Loo B, Labugger R, Skepper JN, et al. Enhanced peroxynitrite formation is associated with vascular aging. J Exp Med. 2000;192:1731–1743
  160. Hamilton CA, Brosnan MJ, McIntyre M, et al. Superoxide excess in hypertension and aging: a common cause of endothelial dysfunction. Hypertension. 2001;37:529–534
  161. Mollnau H, Wendt M, Szocs K, et al. Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circ Res. 2002;90:E58–E65
  162. Csiszar A, Ungvari Z, Edwards JG, et al. Aging-induced phenotypic changes and oxidative stress impair coronary arteriolar function. Circ Res. 2002;90:1159–1166
  163. Sun D, Huang A, Yan EH, et al. Reduced release of nitric oxide to shear stress in mesenteric arteries of aged rats. Am J Physiol Heart Circ Physiol. 2004;286:H2249–H2256
  164. Wendt T, Bucciarelli L, Qu W, et al. Receptor for advanced glycation endproducts (RAGE) and vascular inflammation: insights into the pathogenesis of macrovascular complications in diabetes. Curr Atheroscler Rep. 2002;4:228–237
  165. Pauly RR, Passaniti A, Bilato C, et al. Migration of cultured vascular smooth muscle cells through a basement membrane barrier requires type IV collagenase activity and is inhibited by cellular differentiation. Circ Res. 1994;75:41–54
  166. Cheng L, Mantile G, Pauly R, et al. Adenovirus-mediated gene transfer of the human tissue inhibitor of metalloproteinase-2 blocks vascular smooth muscle cell invasiveness in vitro and modulates neointimal development in vivo. Circulation. 1998;98:2195–2201
  167. McNulty M, Spier JP, McGoven E, et al. Aging is associated with increased MMP-2 activity in the human aorta. Am J Hypertens. 2005;18:504–509
  168. Bilato C, Crow MT. Atherosclerosis and the vascular biology of aging (Milano). Aging. 1996;8:221–234
  169. Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation. 2001;104:365–372
  170. Daugherty A, Cassis L. Angiotensin II-mediated development of vascular diseases. Trends Cardiovasc Med. 2004;14:117–120
  171. Hosomi N, Noma T, Ohyama H, et al. Vascular proliferation and transforming growth factorbeta expression in pre- and early stage of diabetes mellitus in Otsuka Long-Evans Tokushima fatty rats. Atherosclerosis. 2002;162:69–76
  172. Carrieri G, Marzi E, Olivieri F, et al. The G/C915 polymorphism of transforming growth factor beta1 is associated with human longevity: a study in Italian centenarians. Aging Cell. 2004;3:443–448
  173. Lawrence DA. Latent-TGF-beta: an overview. Mol Cell Biochem. 2001;219:163–170
  174. Karsdal MA, Larsen L, Engsig MT, et al. Matrix metalloproteinase-dependent activation of latent transforming growth factor-beta controls the conversion of osteoblasts into osteocytes by blocking osteoblast apoptosis. J Biol Chem. 2002;277:44061–44067
  175. Wang M, Zhang J, Spinetti G, et al. Angiotensin II activates matrix metalloproteinase type II and mimics age associated carotid arterial remodeling in young rats. Am J Pathol. 2005;167:1429–1442
  176. Wahl SM. Transforming growth factor-beta (TGF-beta) in inflammation: a cause and a cure. J Clin Immunol. 1992;12:61–74
  177. McCaffrey TA, Du B, Consigli S, et al. Genomic instability in the type TGF-β1 receptor gene in atherosclerosis and restenotic vascular cells. J Clin Invest. 1997;100:2182–2188
  178. Shull MM, Ormsby I, Kier AB, et al. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature. 1992;359:693–699
  179. Huynh ML, Fadok VA, Henson PM. Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation. J Clin Invest. 2002;109:41–50
  180. McCaffrey TA. TGF-betas and TGF-beta receptors in atherosclerosis. Cytokine Growth Factor Rev. 2000;11:103–114
  181. McCaffrey TA, Falcone DJ. Evidence for an age-associated dysfunction in the antiproliferative response to transforming growth factor-β in vascular smooth muscle cells. Mol Biol Cell. 1993;4:315–322
  182. Li X, Eriksson U. Novel PDGF family members: PDGF-C and PDGF-D. Cytokine Growth Factor Rev. 2003;14:91–98
  183. Sarzani R, Arnaldi G, Takasaki I, et al. Effects of hypertension and aging on platelet-derived growth factor and platelet-derived growth factor receptor expression in rat aorta and heart. Hypertension. 1991;18:III93–III99
  184. Inadera H, Egashira K, Takemoto M, et al. Increase in circulating levels of monocyte chemoattractant protein-1 with aging. J Interferon Cytokine Res. 1999;19:1179–1182
  185. Bursill CA, Channon KM, Greaves DR. The role of chemokines in atherosclerosis: recent evidence from experimental models and population genetics. Curr Opin Lipidol. 2004;15:145–149
  186. Visser M, Pahor M, Taaffe DR, et al. Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study. J Gerontol A Biol Sci Med Sci. 2002;57:M326–M332
  187. Csiszar A, Ungvari Z, Koller A, et al. Aging-induced proinflammatory shift in cytokine expression profile in coronary arteries. FASEB J. 2003;17:1183–1185
  188. Csiszar A, Ungvari Z, Koller A, et al. Proinflammatory phenotype of coronary arteries promotes endothelial apoptosis in aging. Physiol Genomics. 2004;17:21–30
  189. Safar ME, Benetos A. Factors influencing arterial stiffness in systolic hypertension in the elderly: role of sodium and the renin-angiotensin system. Am J Hypertens. 2003;16:249–258
  190. Eggena P, Morin AM, Barrett JD, et al. The influence of aging on angiotensinogen production by rat vascular smooth muscle cells in vitro. Clin Exp Hypertens A. 1988;10:597–603
  191. Challah M, Nadaud S, Philippe M, et al. Circulating and cellular markers of endothelial dysfunction with aging in rats. Am J Physiol. 1997;273:H1941–H1948
  192. Touyz RM, Endemann D, He G, et al. Role of AT2 receptors in angiotensin II-stimulated contraction of small mesenteric arteries in young SHR. Hypertension. 1999;33:366–372
  193. Matrougui K, Loufrani L, Heymes C, et al. Activation of AT(2) receptors by endogenous angiotensin II is involved in flow-induced dilation in rat resistance arteries. Hypertension. 1999;34:659–665
  194. Usui M, Egashira K, Tomita H, et al. Important role of local angiotensin II activity mediated via type 1 receptor in the pathogenesis of cardiovascular inflammatory changes induced by chronic blockade of nitric oxide synthesis in rats. Circulation. 2000;101:305–310
  195. Wang M, Zhao D, Spinetti G, et al. Matrix metalloproteinase 2 activation of transforming growth factor-beta1 (TGF-beta1) and TGF-beta1-type II receptor signaling within the aged arterial wall. Arterioscler Thromb Vasc Biol. 2006;26:1503–1509
  196. Ishibashi M, Hiasa K, Zhao Q, et al. Critical role of monocyte chemoattractant protein-1 receptor CCR2 on monocytes in hypertension-induced vascular inflammation and remodeling. Circ Res. 2004;94:1203–1210
  197. Farmer JA, Torre-Amione G. The rennin-angiotensin system as a risk factor for coronary artery disease. Curr Atheroscler Rep. 2001;3:117–124
  198. Mavri A, Stegnar M, Sentocnik JT, et al. Impact of weight reduction on early carotid atherosclerosis in obese premenopausal women. Obes Res. 2001;9:511–516
  199. Wildman RP, Schott LL, Brockwell S, et al. A dietary and exercise intervention slows menopause-associated progression of subclinical atherosclerosis as measured by intima-media thickness of the carotid arteries. J Am Coll Cardiol. 2004;44:579–585
  200. Fontana L, Meyer TE, Klein S, et al. Long-term calorie restriction is highly effective in reducing the risk for atherosclerosis in humans. Proc Natl Acad Sci U S A. 2004;101:6659–6663
  201. Tanaka H, Safar ME. Influence of lifestyle modification on arterial stiffness and wave reflections. Am J Hypertens. 2005;18:137–144
  202. Avolio AP, Clyde KM, Beard TC, et al. Improved arterial distensibility in normotensive subjects on a low salt diet. Arteriosclerosis. 1986;6:166–169
  203. Hambrecht R, Wolf A, Gielen S, et al. Effect of exercise on coronary endothelial function in patients with coronary artery disease. N Engl J Med. 2000;342:454–460
  204. Hamdy O, Ledbury S, Mullooly C, et al. Lifestyle modification improves endothelial function in obese subjects with the insulin resistance syndrome. Diabetes Care. 2003;26:2119–2125
  205. Raitakari M, Ilvonen T, Ahotupa M, et al. Weight reduction with very-low-caloric diet and endothelial function in overweight adults: role of plasma glucose. Arterioscler Thromb Vasc Biol. 2004;24:124–128
  206. Rywik TM, Blackman R, Yataco AR, et al. Enhanced endothelial vasoreactivity in endurance trained older men. J Appl Physiol. 1999;87:2136–2142
  207. Huang W, Alhenc Gelas F, Osborne-Pellegrin MJ. Protection of the arterial internal elastic lamina by inhibition of the rennin-angiotensin system in the rat. Circ Res. 1998;82:879–890
  208. Michel JB, Heudes D, Michel O, et al. Effect of chronic ANG I-converting enzyme inhibition on aging processes (II. Large arteries). Am J Physiol. 1994;267:R124–R135
  209. Levy BI, Michel JB, Salzmann JL, et al. Remodeling of heart and arteries by chronic converting enzyme inhibition in spontaneously hypertensive rats. Am J Hypertens. 1991;4:240S–245S
  210. Gonzalez Bosc LV, Kurnjek ML, Muller A, et al. Effect of chronic angiotensin II inhibition on the nitric oxide synthase in the normal rat during aging. J Hypertens. 2001;19:1403–1409
  211. Moon SK, Thompson LJ, Madamanchi N, et al. Aging, oxidative responses, and proliferative capacity in cultured mouse aortic smooth muscle cells. Am J Physiol Heart Circ Physiol. 2001;280:H2779–H2788
  212. de Cavanagh EM, Fraga CG, Ferder L, et al. Enalapril and captopril enhance antioxidant defenses in mouse tissues. Am J Physiol. 1997;272:R514–R518
  213. Inserra F, Romano L, Ercole L, et al. Cardiovascular changes by long-term inhibition of the renin-angiotensin system in aging. Hypertension. 1995;25:437–442
  214. Ferder L, Romano LA, Ercole L, et al. Biomolecular changes in the aging myocardium: the effect of enalapril. Am J Hypertens. 1998;11:1297–1304
  215. Ferder LF, Inserra F, Basso N. Advances in our understanding of aging: role of the renin-angiotensin system (review). Curr Opin Pharmacol. 2002;2:189–194
  216. Alder A, Messina E, Sherman B, et al. NAD(P)H oxidase-generated superoxide anion accounts for reduced control of myocardial O2 consumption by NO in old Fischer 344 rats. Am J Physiol Heart Circ Physiol. 2003;285:H1015–H1022
  217. Joffres MR, Hamet P, MacLean DR. Distribution of blood pressure and hypertension in Canada and the United States. Am J Hypertens. 2001;14:1099–1105
  218. Wolf PA, Lewis A. Conner lecture (Contributions of epidemiology to the prevention of stroke). Circulation. 1993;88:2471–2478
  219. Arnold AM, Psaty BM, Kuller LH, et al. Redrawn from incidence of cardiovascular disease in older Americans: the Cardiovascular Health Study. J Am Geriatr Soc. 2005;53:211–218
  220. Ho KK, Pinsky JL, Kannel WB, et al. The epidemiology of heart failure: the Framingham Heart Study. J Am Coll Cardiol. 1993;22:6A–13A
  221. Pearson JD, Morrell CH, Brant LJ, et al. Age-associated changes in blood pressure in a longitudinal study of healthy men and women. J Gerontol Med Sci. 1997;52:M177–M183
  222. Mattace-Raso FU, van der Cammen TJ, Hofman A, et al. Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Circulation. 2006;113:657–663
  223. Tanaka H, DeSouza CA, Seals DR. From absence of age-related increase in central arterial stiffness in physically active women. Arterioscler Thromb Vasc Biol. 1998;18:127–132

 This research was supported by the Intramural Research Program of the National Institutes of Health, National Institute on Aging.

 Conflict of interest: none.

PII: S1933-1711(07)00120-9

doi: 10.1016/j.jash.2007.05.001

Journal of the American Society of Hypertension
Volume 1, Issue 5 , Pages 302-340 , September 2007

Article Tools

* Image Usage & Resolution